2. Obesity and obstructive sleep apnea syndrome

Internal Medicine

Volumn 38, Issue 2, 1999, Pages 200-202

  Chin, Kazuo ^a   Ohi, Motoharu ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Cardiovascular disease; Fibrinogen; Heat shock protein; Mortality; Nasal continuous positive airway pressure (nCPAP)

Indexed keywords

HEAT SHOCK PROTEIN;

ADIPOSE TISSUE; ADRENERGIC SYSTEM; BLOOD; BLOOD CLOTTING; HEALTH; HEART; HUMAN; INNERVATION; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; REVIEW; SLEEP APNEA SYNDROME;

ADIPOSE TISSUE; BLOOD COAGULATION; HEART; HEAT-SHOCK PROTEINS; HUMANS; OBESITY; PREVALENCE; SLEEP APNEA SYNDROMES; SYMPATHETIC NERVOUS SYSTEM; WORLD HEALTH;

EID: 0033071728     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.200     Document Type: Article

References (20)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328: 1230, 1993.
2. Davies RJ, Stradling JR. The epidemiology of sleep apnoea. Thorax 51 Suppl 2: S65, 1996.
3. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 94: 9, 1988.
4. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 94: 1200, 1988.
5. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Dearly IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 109: 1470, 1996.
6. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1: 862, 1981.
7. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. I Clin Invest 96: 1897, 1995.
8. Carlson J, Davies R, Ehlenz K, et al. Obstructive sleep apnea and blood pressure elevation: what is the relationship? Working Group on OSA and Hypertension. Blood Press 2: 166, 1993.
9. Parsell DA, Lindquist S. The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu Rev Genet 27: 437, 1993.
10. Nakamura T, Tokunaga K, Shimomura I, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 107: 239, 1994.
11. Chin K, Ohi M, Kita H, et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 153: 1972, 1996.
12. Chin K, Kita H, Noguchi T, et al. Improvement of factor VII clotting activity following long-term NCPAP treatment in obstructive sleep apnoea syndrome. QJ Med 91: 627, 1998.
13. Otsuka N, Ohi M, Chin K, et al. Assessment of cardiac sympathetic function with iodine-123-MIBG imaging in obstructive sleep apnea syndrome. J Nucl Med 38: 567, 1997.
14. Noguchi T, Chin K, Ohi M, et al. Heat shock protein 72 level decreases during sleep in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 155: 1316, 1997.
15. Chin K, Ohi M. New insights into the therapy and pathophysiology of patients with obstructive sleep apnoea syndrome. Respirology 3: 139, 1998.
16. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311: 501, 1984.
17. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 258: 1183, 1987.
18. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 2: 533, 1986.
19. de Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 81: 107, 1990.
20. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 108: 625, 1995.